Home » Agenda » Day 2

2nd Patient Empowerment World Congress 2026 Europe

““Part of Patient Centricity & Collaboration Series”

“Connecting Patients, Clinicians, Industry and Policymakers to Transform Healthcare Through Partnership, Innovation and Empowerment.”

Hilton London Kensington, London, United Kingdom

Day 2 - Thursday 15th October 2026

HEALTH EQUITY, ACCESS & PATIENT ADVOCACY

  • Examining the structures necessary to support and mandate patient involvement.
  • Strategies for implementing and expanding these models across diverse healthcare systems.
  • Exploring the vital role of partnerships between different stakeholders in the healthcare ecosystem.
  • Ensuring that patient engagement initiatives are accessible and representative of all populations.

Moderator:


Panelists:

  • Identifying and connecting with groups that currently lack adequate healthcare representation.
  • Ensuring that messaging is respectful of and responsive to diverse cultural health beliefs and practices.
  • Developing robust frameworks to involve local communities in the healthcare process.
  • Identifying and eliminating the systemic and practical obstacles that prevent individuals from receiving care.
  • An analysis of current standards and what regulators now require from stakeholders.
  • Strategies for ensuring the patient voice directly influences the policy-making process.
  • A review of successful international models and frameworks that have effectively integrated patient-centered care.
  • Addressing the upcoming shifts in policy and how organizations can prepare for evolving requirements.
  • The evolving role of patient communities and advocacy organizations in the current healthcare landscape.
  • The implementation and impact of peer education and support programs.
  • The development of community-led health initiatives.
  • Strategies for expanding patient leadership within these networks.
  • Integrating patient insights into every stage of the medicine lifecycle, from discovery to post-market support
  • Designing clinical trials that reduce patient burden and improve recruitment, diversity, and retention
  • Using patient-reported outcomes and real-world evidence to demonstrate value and improve therapies
  • Building transparent partnerships between pharmaceutical companies, clinicians, and patient organisations
  • Leveraging digital tools, remote monitoring, and AI to support patient self-management and engagement
  • Integrating digital health platforms with healthcare systems to create seamless patient experiences
  • Collaborating across healthcare, technology, and pharma to scale patient-centric digital solutions
  • Ensuring accessibility, trust, and data privacy while expanding digital health innovation for patients
  • Moving beyond clinical treatment to address comprehensive patient needs.
  • Incorporating digital monitoring tools to enhance oversight and engagement.
  • Focusing on measurable improvements in treatment adherence and patient well-being.
  • Establishing clear protocols for measuring the overall success and impact of the programme.

PHARMA & LIFE SCIENCE DRIVING PATIENT-CENTRIC INNOVATION

  • Establishing clear channels of information to foster long-term patient relationships.
  • Implementing robust standards for compliant and patient-centric interaction.
  • Developing proactive strategies to counteract inaccurate health information.
  • Clearly articulating the tangible benefits of pharmaceutical innovation and care.
  • Integrating patient insights from the initial discovery phase through to post-market engagement.
  • Strengthening partnerships with patient advocacy groups to better align goals.
  • Improving communication channels to ensure greater transparency for all stakeholders.
  • Developing sustainable strategies to provide ongoing support for patients.
  • Ensuring that patient perspectives are incorporated early in the research and development phase.
  • Developing treatments that accurately reflect the practical requirements of patients.
  • Improving engagement strategies to increase involvement in clinical trials.
  • Focusing on data and results that hold the most significance for the patient experience.
  • Strategies for seamless coordination across various healthcare services.
  • Leveraging emerging technologies to improve clinical outcomes and operational efficiency.
  • Driving innovation through partnerships between public, private, and non-profit sectors.
  • Developing tools and policies that put health management directly into the hands of patients.
  • Defining the specific, necessary steps that stakeholders must take to advance patient-centric care.
  • Developing strategies to effectively scale collaboration across diverse healthcare systems.
  • Establishing frameworks to transition patient empowerment from a conceptual goal into tangible, measurable results.
  • How to best align efforts to achieve these goals?

Emma Sutcliffe, Founder, ISPEP

Jennifer Costello, Executive Director, Global Patient Outreach (GPO), Bristol Myers Squib

Gold Sponsor

Scroll to Top